Menu

Accelerate Diagnostics, Inc. AXDX

Full chart Compare
Set alert

Price alert · AXDX

All alert types
0.03 0.00 (+0.00%)

At closeMay 14, 2025, 4:00 PM EDT

0.034 Day range 0.08

52-week range unavailable

Revenue & Expenses

Revenue by
Income Tax Benefit → Expenses: $66.00KProduct → Revenue: $10.22MExpenses → Selling, General & Admin: $21.33MExpenses → Research & Development: $16.69MExpenses → Interest Expense: $13.12MExpenses → Other Expenses: $1.68MGross Profit → Expenses: $2.70MRevenue → Gross Profit: $2.70MRevenue → Cost of Revenue: $8.99MNet Loss → Expenses: $50.05MService → Revenue: $1.48MIncome Tax Benefit$66.00KGross Profit$2.70MNet Loss$50.05MCost of Revenue$8.99MExpenses$52.81MSelling, General & Admin$21.33MResearch & Development$16.69MInterest Expense$13.12MOther Expenses$1.68MRevenue$11.70MProduct$10.22MService$1.48M

Latest period ending Dec 31, 2024 · select a line to chart its full history

AXDX annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
11.70M12.06M12.75M11.78M11.16M
2.70M2.55M3.30M-381.00K4.46M
-35.31M-54.03M-62.80M-71.56M-63.70M
-50.05M-61.62M-62.49M-77.70M-78.21M
-2.15-4.94-7.61-12.59-14.00
AXDX annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
15.10M12.14M34.91M39.90M35.78M
28.56M31.37M65.02M83.05M93.42M
84.60M51.25M87.28M118.12M156.24M
66.58M39.22M77.54M111.11M149.98M
-56.04M-19.89M-22.26M-35.07M-62.81M
AXDX annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-24.19M-40.20M-48.73M-47.32M-50.39M
-509.00K8.66M12.42M8.30M13.61M
27.05M9.02M31.63M43.23M11.63M
-509.00K-1.03M-554.00K-603.00K-1.36M
2.96M-22.77M-4.99M4.12M-25.23M